Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-7.62%
+1.08%
+1.73%
-0.52%
-12.59%
BABA
Alibaba Group
$117.39
Chart
$114.75 (+2.30%)
$108.87 (+7.83%)
$139.95 (-16.12%)
$78.62 (+49.31%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.62%
+1.08%
+1.73%
-0.52%
-12.59%
BABA
Alibaba Group
Current Price
$117.39
Buy
Login to view Alibaba Group (BABA) recommendation from the last 90 days from financial news and social media.
Chart
$114.75 (+2.30%)
$108.87 (+7.83%)
$139.95 (-16.12%)
$78.62 (+49.31%)
BABA Latest Analysis
Could Alibaba Stock Be on the Rise? Heres What Experts Say.
Today
Alibaba Intensifies Instant Delivery Fight With New Campaign. ) is intensifying its efforts in China’.s fiercely competitive instant delivery market by launching a new 100-day Super Saturdays campaign under its Taobao Shangou brand.This initiative by SCMP on Tuesday aims to significantly boost daily order volumes and draw users away from formidable rivals like ) (OTC:) and ).Through “.Super Saturdays”. consumers can receive substantial subsidies up to 188 Chinese yuan (approximat
Wed Jul 16, 2025
Is It Worth Investing in Alibaba (BABA) Based on Wall Streets ish Views?. The average brokerage recommendation (ABR) for Alibaba (BABA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So is it worth buying the stock?
Tue Jul 15, 2025
Alibaba to $300? Why Qwen3 AI Could Trigger the Next Big Rally.. Alibaba (NYSE: BABA) is back -- and its not just about e-commerce anymore. With a powerful new AI model and billions left in buybacks this forgotten tech giant may be gearing up for a major rally. Is BABA the sleeper stock of the AI revolution? Heres what Wall Street is missin
Mon Jul 14, 2025
The Zacks Analyst Blog Highlights Microsoft Alibaba Group Merck Monarch Cement and Team. MSFT BABA and MRK headline todays top analyst picks with AI global e-commerce and oncology driving mixed growth stories.
Mon Jul 14, 2025
Its About A Fetishization Of Overwork Rather Than Smart Work Why These Tech Leaders Are Pushing Back Against 996 Work Culture. Venture capital Fund 20VC founder Harry Stebbings made a LinkedIn post in June that sparked a debate among European tech leaders about the culture of overworking.What European founders need to realize: The valley has turned up the intensity once again. Seven days a week is the velocity required to win right now the read. There is no room for slip up. You aren'.t com
Mon Jul 14, 2025
Alibaba-backed Moonshots Kimi K2 AI challenges Claude and ChatGPT with cheaper and better coding.
Mon Jul 14, 2025
Alibaba Bleeds Billions As Delivery Price War Erases $100 Billion In Market Value. ) of 80 million on-demand deliveries on Saturday intensifying its competition with ) (OTC:) and ) in China’.s high-stakes quick-delivery market. The e-commerce firm has leaned heavily on giveaways and aggressive discounts to attract users SCMP on Monday. Taobao Shangou Alibaba’.s newly launched instant commerce brand stated that its daily active users rose 15% week-over-week bringing the estimated tota
Mon Jul 14, 2025
Alibaba-backed Moonshot releases new Kimi AI model that beats ChatGPT Claude in coding — and it costs less. Alibaba-backed startup Moonshot released its Kimi K2 model as a low-cost open source large language model the two factors underlying DeepSeeks disruption.
Mon Jul 14, 2025
Top Analyst Reports for Microsoft Alibaba & Merck. MSFT BABA and MRK lead todays top analyst picks with AI e-commerce and cancer drug strategies in sharp focus.
Fri Jul 11, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BABA Stock trends
BABA Stock performance
BABA Stock analysis
BABA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings